HMicro, which makes wireless system-on-a-chip biosensor tech, raised a $10.2 million Series C round. It will use the funding to drive the development and commercialization of its biosensor platform, disposable wireless patch and mobile and fixed location receiver devices.
Fremont, CA-based HMicro was founded in 2008 to develop a silicon-based wireless sensing platform and related products for medical companies, HMicro said in a statement. Its Reach Module platform includes a chip, biosensor patches and receiver devices for use in medical devices.
HMicro is co-developing wireless, clinical-grade devices for the monitoring of physiology, according to the company. Its first focus is a single-patient ECG device. Using its wireless technology, HMicro hopes to replace the wiring harness used in ECG–electrodes attached to the chest and leads connecting them to the patient monitor–with a much smaller wireless solution. HMicro will announce relationships with various partners “in the coming months,” said CEO Surendar Magar in the statement.
OEM Partners, which will be commercializing Reach-based products, participated in the round, along with existing investors XSeed Capital, Seraph Group and Uniquest. HMicro previously raised $5.5 million in a 2014 Series B round.
“We are excited to expand our equity partnerships to firms who will be immediately leveraging our technology into their development initiatives and customer solution roadmaps,
” Magar said in the statement. “Migrating clinical healthcare to the wireless domain is a huge challenge which we believe is best met by pooling resources from committed supply and OEM partners.”